Ion Beam Applications SA's latest sales figures may change the minds of naysayers who doubt whether proton therapy for cancer would really take off because it is too expensive for widespread clinical use.
The Belgian company reported a 41% jump in proton therapy sales for the first six months of 2016, at €96.6m. This impressive growth more than offset a slight 4% decline...